Stock Screener App

무료 -

Pharmaceutical Retailers

7.46

1.91% 0.14

after-market

시간 외 거래: 7.46

Scienture Holdings Inc (SCNX)

개요 뉴스 가격 이력 토론 예측

Scienture Holdings Inc 주식(SCNX)의 최신 뉴스

Scienture Holdings Unveils New Identity Post-Merger - TipRanks

TRxADE Health rebrands as Scienture Holdings with new ticker SCNX - Investing.com

SCNXScienture Holdings, Inc. Latest Stock News & Market Updates - StockTitan

Trxade Health announces name change to Scienture Holdings - TipRanks

TRxADE Health, Inc. Announces Name Change to Scienture Holdings, Inc. - StockTitan

TRxADE HEALTH completes all-stock merger deal with Scienture - World Pharmaceutical Frontiers

$103M all-stock transaction merges TRxADE and Scienture, forming new company - Investing.com

TRxADE Health, Inc. Files its Q1 10-Q; Reporting Positive Net Income Due to Asset Sale - StockTitan

Alumis looks to raise $300 million in IPO. Here’s what you need to know - AlphaStreet

Tempus AI gears up for IPO. Here’s everything you need to know - AlphaStreet

Femasys is committed to providing women with revolutionary healthcare products: CEO - AlphaStreet

Nordic Group makes another acquisition to diversify earnings base - Yahoo Finance

symbol__ Stock Quote Price and Forecast - CNN

Continued focus on core B2B segment drives new business: Trxade CEO Suren Ajjarapu - AlphaStreet

Trxade (MEDS) is increasing the breadth of product offerings: CEO Suren Ajjarapu - AlphaStreet

No concerns on margin side: Trxade (MEDS) CEO Suren Ajjarapu - AlphaStreet

MEDS Stock Price and Chart — NASDAQ:MEDS - TradingView

Trxade Group, Inc. Elects Donald Almeida to Board of Directors - Marketscreener.com

$1.79

5.36%

$0.8707

8.84%

$22.50

1.32%

$17.75

10.94%

$3.68

1.10%

야후에서 열기 | 구글에서 열기 | 핀비즈에서 열기 | Open in MarketWatch | Open in EDGAR | Open in Reuters